The crystal structure of a ␤Thr26Ala mutant of human follicle-stimulating hormone (hFSH) has been determined to 3.0 Å resolution. The hFSH mutant was expressed in baculovirus-infected Hi5 insect cells and purified by affinity chromatography, using a ␤hFSH-specific monoclonal antibody. The ␤Thr26Ala mutation results in elimination of the ␤Asn24 glycosylation site, yielding protein more suitable for crystallization without affecting the receptor binding and signal transduction activity of the glycohormone. The crystal structure has two independent hFSH molecules in the asymmetric unit and a solvent content of about 80%. The ␣-and ␤subunits of hFSH have similar folds, consisting of central cystine-knot motifs from which three ␤-hairpins extend. The two subunits associate very tightly in a head-to-tail arrangement, forming an elongated, slightly curved structure, similar to that of human chorionic gonadotropin (hCG). The hFSH heterodimers differ only in the conformations of the amino and carboxy termini and the second loop of the ␤-subunit (L2␤). Detailed comparison of the structures of hFSH and hCG reveals several differences in the ␤-subunits that may be important with respect to receptor binding specificity or signal transduction. These differences include conformational changes and/or differential distributions of polar or charged residues in loops L3␤ (hFSH residues 62-73), the cystine noose, or determinant loop (residues 87-94), and the carboxy-terminal loop (residues 94-104). An additional interesting feature of the hFSH structure is an extensive hydrophobic patch in the area formed by loops ␣L1, ␣L3, and ␤L2. Glycosylation at ␣Asn52 is well known to be required for full signal transduction activity and heterodimer stability. The structure reveals an intersubunit hydrogen bonding interaction between this carbohydrate and ␤Tyr58, an indication of a mechanism by which the carbohydrate may stabilize the heterodimer. (Molecular Endocrinology 15: 378-389, 2001)
INTRODUCTION
FSH is a member of the family of pituitary glycoprotein hormones (GPH) that play key roles in human fertility. The GPH, which also include CG, LH, and TSH, are heterodimers, each consisting of a common ␣-subunit (92 amino acids) and a unique ␤-subunit (111 amino acids in FSH) (1) (2) (3) (4) . FSH acts by binding to G proteincoupled receptors that signal, in part, through the protein kinase A pathway (5, 6) . FSH enables ovarian folliculogenesis to the antral follicle stage and is essential for Sertoli cell proliferation and maintenance of sperm quality in the testis. The amino acids in GPH that have been identified as critical for receptor binding are striking in similarity, yet they are not the residues essential for signal transduction (7) . Identification of GPH residues that are key to signal transduction could provide for the development of molecular mimetics or antagonists of GPH action, with clinical applications in fertility management (8) and treatment of thyroid disorders (9) .
Glycosylation of the GPH has been shown to be important in circulatory persistence and clearance, and in bioactivity (10) (11) (12) (13) (14) . Each subunit contains two glycosylation sites: at Asn52 and Asn78 in the ␣-subunit and at conserved sites in the ␤-subunit, Asn7 and Asn24 in human FSH (hFSH). ␤-Subunit glycosylation has been reported to affect disulfide bond formation and rate of secretion, with site 2 having a greater effect than site 1, especially on secretion (15) . Glycosylation at ␣Asn78 appears to be important for thermal stability (16) . Deglycosylation of hFSH and hCG at ␣Asn52 has long been accepted to impair signal transduction while allowing full binding activity, suggesting that receptor binding and signal transduction are two separate functions involving different residues and that the carbohydrate is key to signal transduction. Recent evidence suggests that deglycosylation at ␣Asn52 causes hCG to be metastable, and dissociation of the subunits occurs at 37 C (17) . In that study, disulfide bonds engineered between the subunits could overcome the effect of deglycosylation on signal transduction. Although such studies have not been performed for hFSH, they obscure previous results with deglycosylated GPH and demonstrate that the carbohydrate at ␣Asn52 is not essential for full signal transduction if the subunit association is otherwise stabilized. It remains unclear whether the carbohydrate, or the lack of it, affects the structure of all GPH, or whether the formation of intersubunit disulfide bonds stabilizes hCG in a conformation that is signal transduction competent.
Previous structural studies of GPH heteroolimers are limited to two independent reports of the crystal structure of human CG (hCG), partially deglycosylated by hydrogen fluoride treatment (3, 4) , and a recent report of a low resolution structure of the ternary complex of fully glycosylated hCG with two Fv fragments (18) . With the goal of determining the structure of fully active, glycosylated hFSH, we achieved high-level expression of hFSH in Hi5 insect cells and established a method for purification that produces biologically active hFSH. As part of studies of the glycosylation of hFSH, it was observed that glycosylation at Asn24 of the ␤-subunit is detectable in only about half of the molecules (7). To reduce glycoform heterogeneity, in anticipation that this would facilitate crystallization, glycosylation at ␤Asn24 was eliminated by sitedirected mutagenesis, converting Thr26 to Ala. This isoform of hFSH was fully active and yielded crystals suitable for x-ray diffraction. Here, we report the structure of ␤T26A-hFSH and compare it to that of hCG.
RESULTS AND DISCUSSION

Characterization of Recombinant hFSH-␤T26A
Amino acid sequencing of purified, Hi5 insect cellexpressed, hFSH-␤T26A revealed N termini of ␣-AP-DVQDCPEC and ␤-CELTNITIAI, indicating that the ␣-subunit signal peptide was cleaved as in mammalian cells but that the ␤-subunit lacked the two aminoterminal residues (Asn, Ser). Purified hFSH-␤T26A was similar in activity to hFSH expressed in insect cells, was stable during a 16-h incubation period at room temperature, and bound receptor, effectively competing with labeled pituitary hFSH for binding to hFSH receptors expressed in Chinese hamster ovary (CHO) cells (Fig. 1A) . As expected, the biological activity of hFSH-␤T26A was indistinguishable from wild-type hFSH, showing dose-response-related stimulation of progesterone production (Fig. 1B) and cAMP production (Fig. 1C ) in Y1 cells stably transfected with hFSHR.
Crystallization
The first hFSH crystals were obtained for glycohormone that was extracted from human pituitary glands, purified as previously described (19) and desialylated by neuraminidase treatment. These crystals grew from 1.4 M (NH 4 ) 2 SO 4 in phosphate buffer at pH 7.4. They were very large, up to 0.5 mm in all three dimensions, I-hFSH (pituitary) for hFSH receptors expressed in CHO cells. B, Progesterone production induced by wild-type hFSH or ␤T26A hFSH, measured in an in vitro bioassay. C, cAMP production induced by treatment with either wild-type hFSH or ␤T26A hFSH. but required about 6 months to grow to full size and diffracted inconsistently, with some crystals diffracting to 3.8 Å resolution but most diffracting to less than 5.0 Å resolution. Next, crystals of insect cell-expressed wild-type hFSH were grown, initially starting by crossseeding with crystals of the pituitary hFSH. These crystals were more consistent in quality, all diffracting to about 4.0 Å resolution, but still required several months to grow. The crystals of the ␤T26A mutant were grown by macroseeding methods under similar conditions, and initial crystals were obtained by crossseeding with the recombinant wild-type hFSH. The final crystallization conditions were similar to those of the initial pituitary protein conditions, except that the crystals grew most consistently at pH 9.0. Crystals grew to full size in less than 1 month and all were of similar diffraction quality.
Structure Determination
The crystals belong to space group P4 1 2 1 2 with cell parameters, a ϭ 128.3 Å, c ϭ 155.2 Å. Structure determination revealed the presence of two hFSH molecules in the asymmetric unit, with a solvent content of about 80%. The structure was determined by multiple isomorphous replacement with anomalous scattering, using four heavy atom derivatives, followed by solvent flattening. Continuous electron density for more than 95% of the main chain was observed in the initial 3.5Å electron density map (Fig. 2) . The model was refined to an R value of 0.259 and an R free of 0.294 (2,584 reflections, 9.7% of the total data set) for all data from 30 to 3.0 Å resolution. The final model contains residues ␣5 to ␣90 and ␤3 to ␤109 in hFSH molecule 1 (hFSH1) and residues ␣5 to ␣90 and ␤3 to ␤108 in hFSH molecule 2 (hFSH2) in addition to 14 sugar residues and 2 sulfate ions. No attempt was made to include other solvent molecules because of the relatively low resolution of the structure and the uncertainty of the location of the disordered protein and carbohydrate moieties. Thermal parameter refinement was performed in a blocked mode, with main chain atoms and side chain atoms of each residue represented as separate blocks. The thermal parameters are high, due to a combination of the high solvent content and the high flexibility of the molecule, with an average for all protein atoms of 58 Å 2 and ranging from 28 Å 2 for residues in the core of the molecule to 100 Å 2 in some loops. Figure 2 shows the initial experimental electron density maps of a representative loop, residues ␤87-94. The atomic coordinates and structure factors have been deposited with the Protein Data Bank, RCSB, entry number 1FL7.
Overall Structure
As expected, hFSH (Fig. 3) belongs to the family of cystine-knot growth factors (20, 21) and the overall fold is identical to that of hCG. Both the ␣-and ␤-subunits have similar topologies, in which the cystine knot is the central motif. In this motif, a disulfide bond between Cys ␣10 (␤3) and ␣60 (␤51) passes through a ring defined by disulfide bonds from Cys 28 to 82 and from Cys 32 to 84. Three ␤-hairpins extend from the cystine knot, two of which end in tight ␤-turns at one end of the molecule (loops L1 and L3), while the other one forms a longer, more open loop (L2) at the opposite end. The L2 loop of the ␣-subunit (␣L2) includes the only helical segment in the molecule, a 1.5-turn ␣-helix that runs nearly perpendicular to the ␤-strands. The ␤-hairpins are stabilized by, and associate through, disulfide bridges. The disulfide bond pairings of hFSH, ␣7-31, ␣10-60, ␣28-82, ␣32-84, ␣59-87 and ␤3-51, ␤17-66, ␤20-104, ␤28-82, ␤32-84, and ␤87-94, are identical to those of hCG and contradict earlier biochemical assignments (22, 23) . The two subunits are aligned head to tail and are slightly wound around each other so that ␤L2, ␣L1, and ␣L3 form one The model for residues ␤87-94 is shown in black sticks with the disulfide between ␤87-␤94 in a thicker line, and the 3.5 Å experimental electron density map is displayed at a 1.2 -level. The refined average temperature factors for the residues included in the figure were 70Å for the main chain atoms and 85Å for the side chain atoms. Figures 2 and 4 were created using the program Setor (46) . end of the elongated, curved heterodimer and ␣L2, ␤L1, and ␤L3 form the other. The two subunits are intimately associated via intermolecular contacts that bury 32% of the total solvent-accessible surface of the monomers. A loop at the C terminus of the ␤-subunit, residues ␤84-104, wraps around ␤-strands 2 and 3 of the ␣-subunit, resulting in the ␣-subunit being surrounded on both sides by the ␤-subunit. Consequently, this loop has been referred to as the "seat belt" loop in hCG (3).
Insect cell-expressed glycoproteins are glycosylated by short high-mannose type, N-linked oligosaccharides, typically consisting of the core (Man) 4 -(GlcNAc) 2 . In both ␤T26A hFSH molecules, interpretable electron density is observed for the two GlcNAcs at site ␣52 and ␤7 and for two GlcNAcs and one Man at site ␣78. Although some additional density is observed at all three sites in both hFSH molecules, disorder prevents modeling of the remaining oligosaccharide.
Crystal Packing
The two molecules in the asymmetric unit sit close together with their concave surfaces associated in clasped hands-like fashion (Fig. 4) . Residues in loops ␣L2, ␣L3, ␤L2, and the carboxy terminus of the ␣-subunit of hFSH2 contact the carboxy-termini of both hFSH1 subunits as well as the hFSH1 seatbelt. In total, the interactions render approximately 10% of the surface of the heterodimer solvent inaccessible. Intermolecular contacts with symmetry-related molecules are limited to the loops at the ends of the molecules. This packing arrangement results in an open crystal lattice with channels of about 70 Å in diameter. All carbohydrate chains extend into this open channel, as would be expected because the crystals are ultimately derived from the initial crystals produced from the more extensively glycosylated pituitary protein. The average temperature factor of hFSH2, 49 Å 2 , is significantly lower than that of hFSH1, 59Å 2 , possibly due to the slightly larger number of crystal contacts in which hFSH2 is involved.
Comparison of the Two Molecules in the Asymmetric Unit
The conformations of the two hFSH heterodimers in the asymmetric unit are similar, with a root mean square deviation (r.m.s.d.) of 0.9 Å for all 180 ␣-carbon atoms (Fig. 5A ). Although the subunits associate in identical fashion in both heterodimers, there is a small difference in the angle between the subunits, which results in an r.m.s.d. of 1.6 Å between the ␤-subunits when the ␣-subunits are superimposed. This suggests that there is some flexibility in the association of subunits. As expected, the core region of the protein, the cystine knot motifs, and the surrounding ␤-strands have the same conformation in both molecules, and all of the major differences occur in the loops and at the amino and carboxy termini (Fig. 6A) . The C-terminal end of the ␣-helix in loop 2 of the ␣-subunit is less helical in hFSH2, resulting in a shift in the position of the ␣-carbon of residue 48 by 2.4 Å. ␤L2 differs most, with its carboxy-terminal end shifted by about 5.5 Å at residue 43 . This shift appears to be correlated with a major difference in the conformation of the carboxy terminus of the ␣-subunit, which lies in the middle of loop ␤L2 in hFSH2 but is positioned away from the molecule in hFSH1. The final large difference is in ␣L3, which differs by about 3.7 Å in the position of residue 72. While these conformational differences between the two independent observations of the hFSH structure are indicative of the flexibility of the hFSH heterodimer, they are small compared with the differences between hFSH and hCG in many of the same loops.
Comparison with hCG
For the comparisons of the conformations of hFSH and hCG, the hCG coordinates with PDB code 1HCN (4) have been used because this structure was determined at somewhat higher resolution than the 1HRP structure (3). However, the two structures were of the The fold is typical of the cystine-knot growth factors in which both the ␣-subunit (light gray ribbon) and the ␤-subunit (dark gray ribbon) have similar topologies. The carbohydrate and the disulfide bonds in both subunits are represented by ball-and-stick models. The N and C termini of each subunit, the N-glycosylated Asn residues (␤7 ϭ Asn7 from the ␤-subunit), and the loops discussed in the text are labeled. Figures 3, 6 , 7, and 8 were drawn with Molscript (47).
same crystal form and have an r.m.s.d. for all C␣ atoms of 0.7 Å, with maximum main chain differences of approximately 1 Å in some of the loops. In the absence of any systematic differences between the two structures, the conformational analysis presented here is relevant to both structures.
hFSH and hCG have identical folds, but significant differences occur in the amino and carboxy termini and several loops (Figs. 5B and 6B). As expected, the ␣-subunits, with r.m.s.d. values of 1.1 Å and 0.9 Å for the least-squares fit of hCG with hFSH1 and hFSH2, respectively, are more similar than the ␤-subunits, with r.m.s.d. values of 1.5 Å and 1.6 Å. The largest differences in the ␤-subunits occur in the three loops ␤L1, ␤L2, and ␤L3, the cystine noose, and the ␤-subunit carboxy-terminal loop (Fig. 5B) . Loops ␤L1, ␤L2, and␤L3. ␤L1 and ␤L3, together with ␣L2 and the C terminus of the ␤-subunit, form one end of the heterodimer, extending beyond the area where the two subunits interact (Figs. 3 and 6 ). Comparison of the structures reveals large differences in the conformations of hFSH and hCG in this area, but no differences in the two independent molecules of hFSH. The amino acid sequences of hFSH and hCG differ greatly in ␤L3, with only 4 identical residues in the 13-residue span between hFSH residues ␤64 and ␤76. In addition the loop includes three prolines in hCG but only one in hFSH. Consequently, the conformation of ␤L3 of hFSH is a more curved ␤-hairpin than hCG, resulting in a shift toward the concave surface of the heterodimer and nearer to the area of the ␤-subunit carboxy terminus (Fig. 7a) . The distances between corresponding residues in the loop are as large as 6.4 Å (6.8 Å) for hFSH1 (hFSH2). The amino acid sequences in ␤L1 for hFSH and hCG are quite similar (Fig. 5C ) and the conformation of the loop itself is also similar. However, this loop moves by as much as 3.6 Å (3.9 Å) toward the concave side of the molecule in hFSH in concert with ␤L3, because the two loops are tied together by the disulfide bridge, ␤Cys17-␤Cys66. These conformational changes are also correlated with conformational changes in ␣L2 and the C terminus of the ␤-subunit, which are discussed below.
The conformation of hCG loop ␤L2 is quite different from either one of the conformations seen for hFSH (Fig. 6B ), but the two hFSH molecules differ at this locus as much in conformation from each other as they differ from hCG (Fig. 6A ). While the difference between hFSH and hCG in part must result from differences in the sequences in this loop, including a variation in the presence of proline residues (Fig. 5C ), overall this result suggests that the loop is highly flexible in the GPH. Cystine Noose. The cystine noose, or determinant loop, is a short loop between two disulfide-linked cysteines, ␤87 and ␤94 in hFSH (␤93-␤100 in hCG) (24) located toward the center of the concave surface of the molecule, adjacent to ␣L2. Residues in the cystine noose play a role in determining the specificity of hCG receptor (25) and FSH receptor (26) binding. The main chain conformation of the loop is very similar in hFSH and hCG, although the entire loop is shifted by about 3 Å at its tip (Fig. 7b) . This shift is part of the global conformational change at this end of the molecule, also including ␤L1, ␤L3, and ␣L2. More important than the conformational differences between the cystine nooses are their strikingly different surface charge characteristics. There are three negatively charged residues, Asp 88, Asp 90, and Asp 93, and no positively charged residues in hFSH, while hCG has two positively charged residues (Arg 94 and Arg 95) and one negatively charged residue (Asp 99). The conserved aspartic acid residues near the C terminus of the cystine noose, Asp 93 in hFSH and Asp 99 in hCG, have similar conformations in the two hormones. The structure is consistent with the biochemical data since this residue has been shown to be essential for both hFSH activity (7, 27) and hCG activity. The three aspartic acid residues in hFSH create a negatively charged patch on one side of the cystine noose. In contrast, the positively charged arginines in hCG are not arranged to form a charged patch; rather the side chains are directed to opposite sides of the loop (Fig.  7b) . These observations are consistent with biochemical data, showing that while neither hFSH Asp 88 nor Asp 90 is essential for hFSH binding to receptor (27) , both play a role in discriminating between the hFSH and hCG/LH receptors (26) . Sequence comparison (Fig. 5C) shows that the cystine noose and ␤L3 are the only two areas where there is a significant charge differential between hFSH and hCG. The only other possibly significant area is in ␤L2, but the change in The largest deviations between hFSH and hCG are observed in the ␤-subunit loops ␤L1 around residue 25, ␤L2 around residue 50, ␤L3 around residue 80, and at the ␤-carboxy terminus. Large deviations are also observed in loop ␤L2 in the comparison of hFSH1 and hFSH2. This suggests that ␤L2 is quite flexible and can adopt a variety of conformations, while the changes in the other three regions of the protein may be important for receptor discrimination. C, Alignment of the sequences of the ␤-subunits of hFSH (top) and hCG (bottom) with the important loops labeled. The cystine residues involved in the cystine knot are highlighted with filled diamonds of different shades according to their disulfide pairings. The N-glycosylated asparagines are identified by an italicized N. Major sequence differences can be found in ␤L2, ␤L3, the cystine noose, and at the ␤-carboxy terminus. The carboxy terminus of hCG sequence is truncated at residue 111 for clarity. The hCG sequence numbering is indicated in parentheses.
this case is from a generally charged surface in hFSH to a generally uncharged surface in hCG. ␤-Carboxy-Terminal Loop. The carboxy terminus of the hFSH ␤-subunit, residues 95-108, adopts a different conformation than in hCG, with maximum distances between equivalent residues of 7.0 Å (7.0 Å) (Figs. 5B and 6B) at hFSH residue ␤99. Specifically, the loop spanning residues 95-103 in hFSH makes a tighter turn than the equivalent loop from 101-109 in hCG. Both hFSH molecules have identical conformations in this area, despite the fact that this loop in hFSH1 is involved in more intermolecular contacts than in hFSH2. Therefore, differences between hFSH and hCG are caused by divergent sequences in this area (Fig. 5C ). Biochemical data indicate that the ␤-subunit carboxy terminus plays a role in hFSH receptor binding, because alanine substitution of the three residues Arg97-Gly98-Leu99 (27) , as well as replacement of the hFSH residues 95-100 with the corresponding residues of human LH (hLH) (26), diminishes hFSH receptor binding. However, swapping hLH residues for hFSH residues at this locus does not allow for LH receptor binding by the hFSH-LH chimera (26) . The biochemical data are consistent with the structure, in that these residues clearly adopt a different conformation, allowing for differential recognition by the appropriate receptor. However, the changes in this region alone are not sufficient to change the receptor specificity of the hormone.
Glycosylation.
Comparison of the structures of hFSH and hCG indicate that glycosylation has no global effect on the glycohormone conformations. Although the conformation of the insect cell-expressed, and fully active, hFSH differs significantly from that of more extensively deglycosylated, HF-treated hCG in several loops, none of these differences can be directly correlated with differences in the glycosylation. The structure of hFSH reveals one likely mechanism by which the oligosaccharide contributes to heterodimer stability (17) . The nitrogen atom of the acetamido group of the Asn-proximal GlcNAc at ␣Asn52 forms a hydrogen bond with the hydroxyl group of ␤Tyr58, thereby adding an additional intersubunit contact. In hCG, the equivalent residue is Phe64, incapable of forming a similar hydrogen bond, but able to make a hydrophobic interaction with the hydrophobic side of the sugar ring. Indeed, Lapthorn et al. (3) report contacts between the ␣Asn52 carbohydrate and residues ␤Tyr59, ␤Val62, ␤Phe64, ␤Ala83, and ␤Thr97. While the single additional hydrogen bond observed in the hFSH structure may not be adequate to explain the higher stability of the glycosylated heterodimer, it is quite possible that sugar groups not fully defined in the electron density map make additional contacts. Hydrophobic Patch.
A propeller-shaped triad of aromatic residues, ␣Phe17, ␣Phe74, and ␤Tyr39, together with ␣Pro16, ␣Phe18, and ␣Met71, forms a solvent-exposed hydrophobic patch at the end of the hFSH heterodimer composed of loops ␣L1, ␣L3, and ␤L2 (Fig. 7c) . This region includes only three charged residues (␣Lys75, ␤Lys40, and ␤Asp41), all of which are directed away from the hydrophobic patch. In hCG, ␤Leu45 replaces hFSH ␤Tyr 39 and the patch is smaller because of a difference in the conformation of the ␤L2 loop. This area may play a major role in receptor binding. Although the relevance of the ␣L1 loop in hFSH (residues 14-27) has not been evaluated by mutagenesis studies, epitope mapping with monoclonal antibodies revealed a discontinuous immunoneutralizing epitope comprised of residues ␣11-27 and ␣61-92 (29, 30) . Mutational analysis of ␣Phe74 revealed only a modest decrease in hFSH binding to receptor. In contrast to the importance of ␣L1 and ␣L3, alanine scanning mutagenesis has shown that ␤L2 (residues 33-53) is not essential for hFSH binding to receptor (31) . Rather, ␤L2 appears to be important in stabilizing the heterodimer association (32) . ␣-Subunit Carboxy Terminus. The ␣-subunit carboxy terminus has been implicated in receptor binding in hCG (33) (34) (35) , hFSH (36) , and TSH (37) . Clearly, this region is very flexible in hFSH because it adopts different conformations in hFSH1 and hFSH2 and electron density is lacking for the last two residues, ␣91-92. This makes it difficult to draw conclusions about how this region is involved in receptor binding. The only clear difference between hFSH and hCG is the formation of a hydrogen bond between the side chain NH of ␣Arg95 from the cystine noose of hCG with the carbonyl oxygen of ␣89, constraining the conformational flexibility of hCG. This bond is not possible in the hFSH structure, because the hFSH ␣-carboxy terminus is not as close to the cystine noose. This difference in conformation is interesting in the context of receptor interaction, as the residues in the carboxy a, Loops ␤L1 and ␤L3. The conformation adopted by ␤L3 is different in the two hormones due to significant sequence differences. Although the overall sequence and conformation of ␤L1 is similar in hFSH and hCG, the tethering of ␤L1 to ␤L3 by a disulfide bridge results in a concerted movement of the two loops. b, Cystine noose. Sequence variation with respect to charged residues in this area results in a negatively charged patch on one side of the cystine noose in hFSH and several positively charged residues in hCG. This loop may be important for receptor discrimination. c, The solvent-exposed hydrophobic patch in the area of ␣L1, ␣L3, and ␤L2. The size and shape of the patch differs in hFSH and hCG. The unusually large hydrophobic surface area suggests importance for stabilizing intersubunit interaction and possibly for receptor binding.
terminus of the ␣-subunit are essential for hFSH and hCG binding (34) (35) (36) .
Conclusion
The overall structures of hFSH and hCG are similar, but several intriguing differences are observed in specific loops, especially in the ␤-subunit. The largest difference is at one end of the molecule where ␤L1 and ␤L3 move together toward the concave side of the molecule in hFSH compared with hCG. In addition, the ␤L3 loop has a very different conformation as a result of major differences in the amino acid sequence. Currently, no biological data are available regarding the importance of these loops in receptor binding or signal transduction. The three other areas with different conformations, the ␤ carboxy-terminal loop, the cystine noose, and the hydrophobic patch area between loops ␣L1, ␣L3, and ␤L2 also have different surface characteristics. In addition, several residues in these areas have been shown, by scanning alanine mutagenesis or epitope mapping, to play a role in receptor binding (Fig. 8) . Interestingly, the ␤-carboxy-terminal loop, the cystine noose, and the ␤L1 and ␤L3 loops are located on the concave side of the heterodimer (Fig. 8) , resulting in a face that is very different in the two gonadotropins. These differences are therefore very likely to be important for discrimination between hFSH and hCG by their respective receptors.
MATERIALS AND METHODS
Preparation of hFSH Isoform ␤T26A
Site-directed mutagenesis experiments, aimed at elimination of hFSH␤ glycosylation site 2, were performed as previously described for other hFSH mutants (36) . The oligonucleotide used to create the mutation was 5Ј-A-AGC-ATC-AAC-ACC-GCT-TGG-TGT-GCT-GGC-3Ј.
Production of Recombinant hFSH
Production of recombinant hFSH in insect cells was carried out using procedures as previously described (26, 31) . Each production run consisted of about 30 roller bottles, seeded with 1 ϫ 10 8 Hi5 cells and kept at 27 C for 48 h. At that time, virus was added directly to each flask [1.0 MOI (multiplicity of infection) of hFSH␤T26A virus and 3.5 MOI of hFSH␣ virus] and flasks were rotated for an additional 4-5 days. Next, media were collected by centrifugation in 1-liter bottles (2,500 ϫ g, 10 min). The clarified media were pooled and made 1.0 mM with phenylmethylsulfonyl fluoride, and 0.1% with sodium azide. Typically, recombinant hFSH-␤T26A was expressed at levels of 2.7 mg/liter (n ϭ 9) as determined by enzyme-linked immunosorbent assay (ELISA) (32) . Media (typically 4 liters) were then concentrated at 4 C utilizing an Amicon (Waltham, MA) radial flow cartridge (10,000 mwc), to a volume of about 200 ml, and then frozen until processed. The concentrate was thawed, clarified by centrifugation (16,000 ϫ g, 30 min ) and then applied to the affinity column without further processing.
Preparation of the Affinity Support
An affinity column was prepared using monoclonal antibody (mAb) 46. 3 H6.B7. This antibody binds to both the monomeric ␤-subunit of native hFSH, and the heterodimeric hormone, but has no measurable cross-reactivity with the ␣-subunit or with hLH (19, 38) .
The cell line producing mAb 46.3H6.B7 was expanded as ascites tumors in mice (Animal Welfare Committee Approval was obtained for these studies). Approximately 38 ml of 46.3H6.B7 ascitic fluid were diluted 1:3 with PBS and subjected to ammonium sulfate precipitation as follows. Saturated ammonium sulfate (pH 7.2) was added to the diluted ascitic fluid in a ratio of 4.5 volumes of ammonium sulfate solution to 5.5 volumes of antibody. The mixture was stirred (4 C, 30 min), and the antibody precipitate was collected by centrifugation (5, 858 ϫ g, 15 min). Each precipitate was dissolved in PBS and reprecipitated twice as before. Wet pellets were dissolved and dialyzed against 0.01 M potassium phosphate, pH 7.2. Dialyzed samples were clarified by centrifugation, the pH and conductivity were adjusted to the buffer values, and the sample was applied to a 1.9 ϫ 18 cm diethylaminoethyl (DEAE) Sephacel column. Antibody was eluted with a gradient of 0.0-0.2 M NaCl. The procedure used for coupling of the DEAE Sephacel-purified antibody (100 mg) to CNBr-activated Sepharose was exactly as described by the manufacturer (Pharmacia Biotech, Piscataway, NJ).
Fig. 8. Ribbon Image of the Structure of hFSH Highlighting Areas of Interest
Magenta, areas with known biological importance and structural differences with hCG; blue, areas of biological significance but no defined conformational difference with hCG; and, yellow: areas of conformational differences between hFSH and hCG, without known biological relevance. Residues known to be important for hFSH-receptor binding are shown: Lys51 of ␣L2, Ser85, Thr86, Tyr88, and Tyr89 of the carboxy terminus of the ␣-subunit (blue) and Asp93 (red) on the ␤-carboxy terminal loop. The residues forming the exposed hydrophobic patch are shown in green. All areas of interest, except the hydrophobic patch, are located at the concave surface of the molecule.
Purification of hFSH ␤T26A
Concentrates of conditioned media, collected from cells producing hFSH ␤T26A, were applied directly to the affinity support. Typically a flow rate of 0.6 ml/min was used. The mAb 46.3H6.B7 column dimensions were 0.9 ϫ 10 cm. The sample buffer and column buffer were 0.1 M potassium phosphate, made 0.3 M with NaCl, pH 7.0. The absorbance (275 nm) of the fractions was determined during the procedure. After a decrease of absorbance to baseline, elution buffer (0.1 M sodium acetate, pH 2.0, 0.5 M NaCl) was pumped through the column. Fractions were collected into tubes containing 2.0 M Tris base and mixed to neutralize each fraction.
Biological Characterization of hFSH-␤T26A Heterodimer
Recombinant hFSH-␤T26A was compared with wild-type hFSH in a RRA using CHO cells, stably expressing hFSH receptors (36, 39) . Signal transduction induced by hFSH-␤T26A was determined by measuring progesterone (36) or cAMP (38) production by Y1 cells that stably express hFSH receptors (39) .
Protein Crystallization
Crystals of ␤T26A hFSH were grown by macroseeding into drops containing 3 l protein (9 mg/ml in 10 mM Tris, pH 7) and 1 l reservoir solution. The reservoir solution was 100 mM glycine, pH 9.0, and 0.9-1.2 M ammonium sulfate.
Data Collection and Structure Determination
The crystals were transferred to a solution consisting of the crystallization buffer enriched with 25% wt/vol sucrose before flash cooling in liquid nitrogen. The crystals were highly sensitive to the addition of heavy atom compounds. Crystals tolerated soaking in heavy atom solutions for no more than about 10 h, with some heavy atom compounds, especially platinum and mercury compounds resulting in significant degradation of the diffraction quality after as little as 2 h. Data were collected at Stanford Synchrotron Radiation Laboratory (SSRL) Beamline B9.1, processed with MOSFLM (40) , and then scaled and merged with SCALA (40) ( Table 1) . Initial MIRAS phases were calculated using SOLVE (41) ( Table 1) . The correct space group and enantiomer were determining by examining the figure-of-merit (FOM) for both space groups with each hand. This clearly indicated that P4 1 2 1 2 was the correct space group, FOM 0.57 vs. 0.43, and that the positive hand was correct. All four derivatives had relatively weak phasing power due to low occupancy, and the sites of the platinum and osmium derivatives were similar. However, solvent flattening [CCP4 program DM (40) ] greatly improved the quality of the phases because of the very high solvent content of the crystals (ϳ80%). MIRAS phasing in program SOLVE resulted in an overall FOM of 0.57. After solvent flattening, the electron density clearly showed two molecules in the asymmetric unit.
Structure Refinement
An initial model was built into the MIRAS/solvent-flattened electron density map. Rounds of simulated annealing refinement using the torsion angle dynamics option in the CNS (42) were followed by phase combination in SIGMAA (40) before rebuilding in O (43) during early stages of refinement. Once the majority of the sequence had been placed in the model, composite omit maps in CNS were used for rebuilding in an effort to reduce model bias. The quality of the model was monitored throughout with PROCHECK (44) . Grouped temperature factor refinement, where the main chain atoms of each residue formed one group and the side chain atoms formed a second group, was used in later stages of refinement. Thermal parameters that exceeded 100 Å 2 were reset to this value during the refinement. Experiments were done using NCS constraints and restraints to tether the two molecules in the asymmetric unit, but in all cases this caused R free to increase. The final hFSH structure has an R value of 25.9% and an R free of 29.4% for all data from 50.0 to 3.0 Å resolution. The model contains 2,992 protein atoms, 14 carbohydrate residues, and 2 sulfate ions. The geometry is good, with 74.3% of residues in the most favored regions of the Ramachandran plot, and only three residues (0.9%) from the loops in disallowed regions. The r.m.s.d. values from ideality for the protein are as follows: bonds, 0.008 Å; angles, 1.5°; dihedrals, 24.6°; impropers, 1.0°.
Structure Comparisons/Surface Area Calculations
Protein structures were compared using LSQMAN (45) , and values quoted in the text are the results of comparing regions of the structure after the entire structure was superimposed by least-squares fitting of the ␣-carbon atoms only. Solventaccessible surface area was calculated using CNS with a 1.4-Å probe (42). 
